AC
NXTC icon

Armistice Capital’s NextCure NXTC Stock Holding History

Armistice Capital’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,667
Closed -$47.8K – 372
2025
Q2 		$47.8K Hold
8,667
– – ﹤0.01% 192
2025
Q1 		$50K Hold
8,667
– – ﹤0.01% 211
2024
Q4 		$80.2K Buy
8,667
+334
+4% +$4.91K ﹤0.01% 205
2024
Q3 		$137K Buy
8,333
+5,333
+178% +$98.1K ﹤0.01% 229
2024
Q2 		$57.2K Buy
+3,000
New +$58.3K ﹤0.01% 236

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CPA
Cardiff Park Advisors Carlsbad, California $1.29B AUM 23.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Armistice Capital's NXTC Position: Q3 2025 in Review

Armistice Capital sold out of NextCure (NXTC) in Q3 2025, closing a stake of 8,667 shares — an estimated $47.8K sold.

Armistice Capital first reported a position in NXTC in Q2 2024 and held it in 5 quarters. The position peaked at $137K in Q3 2024. 17 funds tracked by Wall St. Rank hold NXTC as of Q3 2025.

  • Armistice Capital reported no remaining NextCure position as of Q3 2025 after selling out during the quarter.
  • Armistice Capital sold 8,667 NextCure shares in Q3 2025, an estimated $47.8K.
  • Armistice Capital first reported a position in NextCure in Q2 2024 and held it in 5 quarters.
  • Armistice Capital's NextCure position peaked at $137K in Q3 2024.
  • 17 funds tracked by Wall St. Rank held NextCure as of Q3 2025.

Based on Armistice Capital's 13F filing for Q3 2025, filed 17 Nov 2025.